Robert Baffi Latest Insider Activity
Management EfficiencyThe company has return on total asset (ROA) of (2.21) % which means that it has lost $2.21 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (4.4) % meaning that it created substantial loss on money invested by shareholders.
Entity SummaryBioMarin Pharmaceutical, Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. The company was founded in 1996 and is headquartered in San Rafael, California. BioMarin Pharmaceutical operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 2581 people.BioMarin Pharmaceutical (BMRN) is traded on BATS Exchange in USA. It is located in California U.S.A and employs 2,581 people. BioMarin Pharmaceutical is listed under Pharmaceutical Products category by Fama And French industry classification.
BioMarin Pharmaceutical Leadership Team
Stock Performance Indicators